Panama vs Tajikistan: Access to anti-retroviral drugs, male
Panama
72.0%
in 2024
Tajikistan
72.0%
in 2024
Panama rank
65th
Tajikistan rank
65th
Access to anti-retroviral drugs, male over time
- Panama
- Tajikistan
How they compare
Panama currently reports 72.0% against 72.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Panama ahead.
Panama ranks 65th and Tajikistan ranks 65th of 141 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Panama | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.6% | 0.7% | 13.9% | Panama |
| 2010s | 41.7% | 19.3% | 22.4% | Panama |
| 2020s | 64.6% | 59.2% | 5.4% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Panama or Tajikistan?
- Panama, at 72.0% against 72.0% in Tajikistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Panama and Tajikistan?
- 0.0%, with Panama ahead.
- How many years of comparable data are there for Panama and Tajikistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Panama and Tajikistan rank globally for access to anti-retroviral drugs, male?
- Panama ranks 65th and Tajikistan ranks 65th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.